Pharma-Biotech Industry Capital Investment Tops $12 Billion for North American Project Starts in 2013

SUGAR LAND--January 14, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--As 2014 slowly gathers steam, it is a good time to review the Pharmaceutical-Biotech Industry's capital and maintenance (MRO) project activity for 2013. Just more than $12 billion worth of projects that actually made it to construction as planned.

Other companies featured: Baxter International Corporation (NYSE:BAX), Merck & Company (NYSE:MRK), Quest Diagnostics (NYSE:DGX), Hewlett-Packard (NYSE:HPQ)